Skip to main content
Log in

Home IV antibacterial therapy

benefits outweigh risks

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Home IV antibacterial therapy. Pharmacoecon. Outcomes News 46, 2 (1996). https://doi.org/10.1007/BF03269768

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03269768

Keywords

Navigation